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Background/aims: To report the generation of a new mouse model for a genetically determined corneal
abnormality that occurred in transgenesis experiments.
Methods: Transgenic mice expressing mutant forms of Rab27a, a GTPase that has been implicated in the
pathogenesis of choroideremia, were generated.
Results: Only one transgenic line (T27aT15) exhibited an unexpected eye phenotype. T27aT15 mice
developed corneal opacities, usually unilateral, and cataracts, resulting in some cases in phthisical eyes.
Histologically, the corneal stroma was thickened and vacuolated, and both epithelium and endothelium
were thinned. The posterior segment of the eye was also affected with abnormal pigmentation, vessel
narrowing, and abnormal leakage of dye upon angiography but was histologically normal.
Conclusion: Eye abnormality in T27aT15 mice results from random insertional mutagenesis of the
transgene as it was only observed in one line. The corneal lesion observed in T27aT15 mice most closely
resembles posterior polymorphous corneal dystrophy and might result from the disruption of the equivalent
mouse locus.
C
orneal dystrophies form a group of rare and hetero-
geneous inherited eye disorders.1 2 They frequently
develop during adolescence and progress gradually
throughout life, but more severe cases are apparent at birth.
Most dystrophies show an autosomal dominant pattern of
transmission. These diseases are typically classified according
to the layer(s) of the cornea primarily affected.2 Stromal
dystrophies include lattice, granular, and macular dystrophy.
Corneal dystrophies that affect the endothelium include
Fuchs’ and posterior polymorphous dystrophy (PPCD).
Transgenesis has been a powerful methodology to study
human disease processes. The use of transgenic disease
models in biomedicine promises to dramatically accelerate
the development of new human diagnostic and therapeutic
treatments. To investigate the involvement of Rab27 in
degenerative retinal diseases and other diseases where
Rab27a might play a role, we generated transgenic mice
overexpressing mutant forms of Rab27a.3 Most of the
transgenic lines generated using this approach revealed the
absence of any eye or other phenotype. However, one
transgenic line exhibited an unexpected corneal phenotype.
The phenotype in this line is probably not due to over-
expression of Rab27a but rather to insertion of the transgene
DNA into the genome. Transgene insertion is random and
can be accompanied by other chromosomal rearrangements
leading to the inactivation or activation of one or more
endogenous genes. We report the phenotypic eye character-
isation of this transgenic line as a possible animal model to
study corneal dystrophy.
MATERIALS AND METHODS
Animals
All animals described here were maintained on 12 hour light/
12 hour dark conditions at the CBS Unit, Imperial College
London, under Home Office Project Licence 70/5056.
Generation of transgenic founders and lines
Transgenic mice expressing Rab27a dominant/negative
(Rab27aT23N and Rab27aN133I) and constitutively active
(Rab27aQ78L) mutant proteins under the control of the
tyrosinase promoter were generated and characterised as
described previously.3 Stable transgenic lines were propa-
gated in the C57BL/6J background and maintained as
hemizygous mice. Homozygous mice of this line were not
produced because of poor breeding and early deaths of
potentially homozygous mice.
Transgenic copy number determination
The number of copies integrated into the genome of
transgenic mice was determined by Southern blotting as
described previously.3 Briefly, 10 mg of transgenic mouse
genomic DNA or wild type genomic DNA mixed with serially
diluted microinjection DNA were digested with Pst I,
separated on a 0.8% agarose gel, blotted onto Hybond-N+
membrane (Amersham Biosciences, Amersham, UK), hybri-
dised with a 32P-labelled probe corresponding to the entire
coding region of Rab27a, and then exposed to Hyperfilm MP
(Amersham) in the presence of an intensifying screen or to a
Multipurpose Screen followed by quantification using a
Cyclotron Storage Phosphor Screen (Packard, Pangbourne,
UK). Copy number was determined from a standard curve
derived from the intensity of the signal in the spiked controls,
assuming one copy of the transgene integration per diploid
genome.
Fundus photography
Fundus photographs of mice were taken using a small animal
fundus camera (Kowa Genesis, Tokyo, Japan).3 4 In order to
have a better magnification and focal depth of the fundus,
the camera was used in conjunction with an external 90
diopter condensing lens (Volk). Pupils were dilated with a
drop of 1% Mydriacyl (Alcon Laboratories, Hemel
Hempstead, UK) 20–30 minutes before taking the photo-
graphs. For conventional photography of the fundus, Kodak
200 ASA slide film was used. The photographic flash on the
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power pack was set up for its highest intensity of light
(position 6–7).
Fluorescein angiography
The retinal angiography was performed using the general
fundus photography procedure.3 4 The camera was set up for
angiography through addition of an emission barrier filter
specific for fluorescein emission, and the power pack was set
up for fluorescein angiography by changing the excitation
light to fluorescein excitation. For this type of photography
Kodak black and white Tmax 400 ASA professional film was
used. The photographic flash on the power pack was set at its
highest level (position 6–7). Mice were injected intraperito-
neally with 20% injectable sodium fluorescein (Faure,
Annonay, France) at a dose of 10 ml per 5–6 g body weight.5
Photographs were taken at several intervals, starting at
30 seconds after injection.
Eye histology
Eyes were fixed in 4% paraformaldehyde, 5% glutaraldehyde,
and 0.1 M cacodylate buffer for 1 hour. Subsequently, the
eyes were cut longitudinally in half to separate the anterior
and posterior segments. Fixed eyes were washed three times
for 10 minutes at room temperature with PBS. Specimens
were embedded in paraffin, sectioned to 3–5 mm thickness
and stained with haematoxylin and eosin (to stain the nuclei
and membranes, respectively) or periodic acid Schiff (PAS; to
stain mucopolysaccharides from cornea).
RESULTS
Generation and characterisation of the T27aT15
transgenic line
Figure 1A provides a schematic diagram of the PTyr/
Rab27aT23N/hGH expression construct.3 PTyr/Rab27aT23N/
hGH includes a 2200 bp fragment of tyrosinase promoter,6
a 650 bp rat Rab27a coding sequence including the T23N
point mutations, and 600 bp of sequence derived from the
human growth factor gene which provides a polyadenylation
signal. Figure 1B provides an example of screening for
T27aT15 transgenic mice by Southern blotting. The analysis
of the restriction digestion pattern revealed the presence of
very strong bands around 3.4 kb, which probably corresponds
to the expected bands for a tandem array of the transgene.
The endogenous bands can hardly be detected in these
Southern blots because of the strong signal derived from the
transgenic bands. We estimate that the T27aT15 line contains
approximately 260 copies of the transgene per cell, based on
phosphor-imager quantification of the Southern blot signal
(data not shown). We characterised four other independent
lines containing the same construct for which we estimated
the transgene copy number to range between 10–180 copies.
The T27aT15 line probably contains a single integration site
of the transgenes as there is no segregation of different
restriction digestion patterns in the F1 generation.
The T27aT15 transgenic line expresses approximately twice
as much transgenic as endogenous Rab27a mRNA (fig 1C).3
Despite the high levels of mRNA, the transgenic protein levels
were undetectable by immunoblot analysis (fig 1D).
However, this result was observed for all other transgenic
lines expressing the Rab27aT23N protein (see for example
T27aT17 in fig 1D) and our results indicate that this is caused
by instability of the mutant Rab27a protein.3
Phenotypic analysis of the anterior segment of the eye
About 20% of T27aT15 transgenic mice exhibited significant
visual disorders. The most striking alterations of the anterior
segment of the eye were corneal opacities and cataract. The
opacity of the cornea, usually unilateral, became apparent at
around 2 months of age and progressed slowly, extending
centrally and circumferentially (fig 2). The opacities were not
sex dependent and involved the visual axis in some cases
resulting in reduced vision. In some of the mice, the corneal
abormality led to a corneal abscess and then endophthalmi-
tis, often associated with other defects such as cataract. This
condition often evolved into phtisis bulbi (fig 2). Paraffin
sections of the cornea stained with PAS revealed thinner
epithelium with fewer cell layers (fig 3, labelled EP).
Vacuoles were seen in the stroma, associated with a
thickening of this layer (fig 3, labelled S). Vascularisation
of the cornea was not observed. In advanced stages of the
disease, the Descemet’s layer and the endothelium could also
be affected (fig 3, labelled EN). However, a multilayered
endothelium that is often characteristic of some corneal
dystrophies was not observed. The abnormalities were
Figure 1 (A) Organisation of the
PTyr/Rab27a/hGH transgenic
construct. The point mutation in Rab27a
is indicated by an asterisk. (B)
Screening for potential transgenic mice
by Southern blotting. Genomic DNA
was extracted from the tail tips of
offspring from a cross between a
T27aT15 transgenic and a wild type
mouse and subjected to Southern
blotting as described under materials
and methods. Mice 4 to 8 are
transgenic. (C) RT-PCR quantification of
transgenic mRNA. Total RNA was
extracted from eyes of adult wild type,
T27aT15 and T27aT17 transgenic mice
and Rab27a mRNA was quantified and
normalised to Hprt expression as
described previously.3 (D) Expression of
transgenic Rab27a proteins. Protein
lysates (50 mg) from wild type,
T27aT15, T27aT17, and A27aQ243
transgenic eyes were subjected to SDS-
PAGE and analysed by immunoblotting
using the monoclonal anti-Rab27a
antibody 4B12 as described
previously.3 Calnexin was used as a
loading control and was detected using
a specific polyclonal antibody.3
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progressive and by approximately six months of age, these
corneal structures became completely disrupted (fig 3).
Phenotypic analysis of the posterior segment of the
eye
In most cases, observation of the eye fundus was hindered by
the presence of corneal and lens opacities. We were never-
theless able to perform retinal analysis in those cases where
anterior segment disease was less obvious. Photographic
studies of retinal fundi of these transgenic mice revealed
abnormal pigmentation around the optical nerve (fig 4).
Furthermore, fluorescein fundus angiography revealed
pathologic findings. Figure 5 depicts typical angiograms
taken at different times after fluorescein dye injection and
revealed abnormal leakage of dye from retinal capillaries. The
arrows in figure 5 highlight an area with possible leakage of
fluorescein dye. However, we do not exclude the possibility
that this represents background fluorescence from the
choriocapillaries shinning through the RPE. Alternatively, it
could be caused by abnormal hyperpigmentation of the RPE
or deficiency (lobular filling) of the choriocapillaries. We also
noted that some mice presented with narrower blood vessels
compared with non-transgenic mice (data not shown). This
lesion seemed to be present only in those mice that developed
serious anterior and posterior segment abnormalities and
usually the eye became phthisical by six months of age. In
addition, small hypopigmented areas that could result in
transmission defects were observed in some of the animals
affected. However, it is questionable whether the transmis-
sion defects were caused by loss of cells (usually RPE cells) or
the pigmentation within cells. In contrast to what was
observed for the cornea, the retina of these mice exhibited a
normal appearance by histochemical analysis (fig 6).
DISCUSSION
In any transgenic mice, insertion of the transgene in the
genome is potentially mutagenic. It has been proposed that
about 5–10% of transgenic mice harbour transgene induced
chromosomal alterations, including deletions and transloca-
tions.7 8 Thus, random insertion of foreign DNA into any
genome is liable to deactivate or activate one or more genes.
The striking eye phenotype observed in the T27aT15
transgenic line seems to be the result of the transgene
insertion into the genome as the phenotype is unique among
more than twenty transgenic lines that were generated using
identical or similar constructs.3
We present a phenotypic characterisation of the T27aT15
line. A proportion of hemizygous transgenic mice developed
serious abnormalities of the eye, usually starting between one
and two months of age. The progressive eye abnormalities
seem to arise after eye formation, as the eye appears to
develop normally. The phenotype of these mice includes
corneal opacity, cataract, and retinal vascular abnormalities.
To date, we have not been able to find a description of mice
with an inherited eye disease resembling that seen in these
mice.
The phenotype observed in T27aT15 does not seem to be
secondary to trauma inflicted upon the cornea, because if this
was the case then the eyes would have been obviously
inflamed as soon as the opacities were evident, there would
have been tearing and discharge from the eye, and the mice
would clearly have been distressed. None of these signs was
evident. Thus, T27aT15 appears to be an example of a new
type of corneal and eye dystrophy in the mouse.
Many different mouse genetic mutations result in catar-
act.9–12 However, there are only a few descriptions of mouse
genetic corneal dystrophies.13–18 In the T27aT15 mice, the
major and possibly primary defect is the dystrophy of the
cornea. The abnormality of the corneal stroma, which
includes the presence of vacuoles, could result from the
heterozygous disruption or activation of a gene required for
organisation and maintenance of this tissue. BIGH3 (trans-
forming growth factor b induced gene) is a gene involved in
corneal dystrophies such as lattice and granular corneal
dystrophies characterised by deposits of amyloid or hyaline in
the stroma.14 19 20 BIGH3 encodes an extracellular matrix
adhesion protein (big-h3) inducible by transforming growth
Figure 2 External photographs of the
eyes of T27aT15 transgenic mice. Eyes
with an advanced abnormality of the
cornea (A), a stromal opacity of the
cornea (B), and a cataract (C) are
shown. The arrow indicates a corneal
abnormality area.
Figure 3 Histochemical staining of T27aT15 mouse cornea. Transverse
paraffin sections (5 mm) from T27aT15 transgenic mouse (B) and from a
littermate control (A) were stained with periodic acid Schiff and
visualised (magnification, 6130) as described under materials and
methods. The abbreviations used are epithelium (EP), the avascular
stroma (S) containing 200–300 parallel lamellae of collagen, and
endothelium (EN). Bar = 300 mm.
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factor b and abundant in the cornea.21 Although big-h3 plays
an important role in cornea physiology, its involvement in
our mice is unlikely, given that the BIGH3 derived dystro-
phies are characterised by stromal deposits rather than
vacuolisation of the stroma. Another possibility is that the
transgenic insertional mutagenesis affected a regulatory
gene, such as Pax6 or a similar gene. Pax6 is a master
regulator of ocular morphogenesis and Pax6 mutations have
been detected in various types of ocular anomalies, including
aniridia, Peter’s anomaly, corneal dystrophy, congenital
cataract, and foveal hypoplasia.17 22 23 The gene is expressed
in the developing central nervous system, as well as in ocular
tissues, including tissues of the corneal epithelium, lens, and
retina. Pax6 is a transcription factor that recognises target
genes through its paired type DNA binding domain.22 23
Another possibility that might explain the phenotype
observed in T27aT15 mice is a multi-locus disruption by the
transgene. Transgene integration is sometimes accompanied
by alterations in the gross structure of the chromosome near
the integration site, resulting in multiple gene inactivation
events. A less likely possibility is multiple integrations of the
transgene in more than one chromosome. In this case, there
is usually segregation in successive generations of the
chromosomes affected, and our observations indicate that
the transgene is stably transmitted through the germ line.
One interesting candidate appears to be the posterior
polymorphous corneal dystrophy locus (PPCD, MIM 122000).
This type of dystrophy is characterised by the presence of
vacuoles in the posterior part of the cornea that can easily be
detected by ophthalmological examination and often by the
presence of multilayered endothelium with characteristics of
an epithelium.24 In T27aT15 mice, similar vacuoles are
detected, although the endothelium appears monolayered
(fig 3). One case of PPCD has been found to be caused by
mutations in the type VIII collagen gene, COL8A2.25 However,
another PPCD locus was mapped to 20p11.2–q11.2.24 Almost
100% of the transgenic mice of the T27aT15 line were agouti
even after four or five generations of backcrossing to C57BL/
Figure 4 Fundus photographs of T27aT15 mice. Three month old wild type (A) and T27aT15 transgenic (B) mouse were examined as described under
materials and methods. Hypopigmentation (a), a stromal opacity of the cornea (b), and a focal patch of RPE hyperpigmentation in the optical nerve
area (c) are indicated. Note also the narrowing of retinal vessels.
Figure 5 Fluorescein fundus angiograms of T27aT15 transgenic mouse
retina. Angiograms were taken at 83, 141, 186, and 343 s after dye
injection. The arrow indicates a leaking area.
Figure 6 Histochemical staining of T27aT15 mouse retina. Transverse
paraffin sections (3 mm) from 3 month old wild type (A) and T27aT15 (B)
mice were stained with haematoxilin and eosin, and visualised
(magnification,6250) as described under materials and methods. SC,
sclera; CH, choroids; RPE, retinal pigment epithelium; ROS,
photoreceptor segments of rods and cones; ONL, nuclei of rods and
cones; OSL, outer synaptic layer; INL, neuron nuclear layer; ISL, inner
synaptic layer; GCL, ganglion cell layer.
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6J mice. This suggests that the transgenic integration is near
to the agouti locus, and that it integrated on the CBA derived
chromosome in the CBA6C57BL/6J F2 embryo into which it
was injected. Intriguingly the human homolog of the agouti
locus, ASIP (agout mouse signaling protein, also known as
AGTI), has been mapped to 20q11.2, near the PPCD locus (see
www.ncbi.nlm.nih.gov/LocusLink/). Taken together, the
similarities of corneal phenotype and human mapping
position suggest that PPCD might be the locus disrupted.
Further studies will be required to better characterise the
genotype and phenotype of these mice and to elucidate the
relation between transgene integration and the phenotype
observed. The mouse model described here represents a new
model for genetic eye disease, and could be particularly
relevant to the study of the pathogenesis of corneal
dystrophy.
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